RHE
Regional Health Properties, Inc. [RHE] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
RHE Stock Summary
Top 10 Correlated ETFs
RHE
Top 10 Correlated Stocks
RHE
In the News
RHE Financial details
Company Rating
Buy
Market Cap
5.15M
Income
-3.89M
Revenue
17.16M
Book val./share
0.1
Cash/share
2.28
Dividend
-
Dividend %
-
Employees
114
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.37
Forward P/E
-
PEG
0.05
P/S
0.17
P/B
10.02
P/C
1.27
P/FCF
3.8
Quick Ratio
1.02
Current Ratio
1.47
Debt / Equity
277.75
LT Debt / Equity
263.74
-
-
EPS (TTM)
-2.08
EPS next Y
-
EPS next Q
-
EPS this Y
-75.65%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-3.14%
Revenue Q/Q
9.28%
EPS Q/Q
-75%
-
-
-
-
SMA20
50%
SMA50
50%
SMA100
50%
Inst Own
0.96%
Inst Trans
0.31%
ROA
-16%
ROE
-578%
ROC
0.03%
Gross Margin
36%
Oper. Margin
9%
Profit Margin
-46%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
1.35-4.52
52W High
-27.5%
52W Low
+190%
RSI
64
Rel Volume
0.06
Avg Volume
5.15K
Volume
299
Perf Week
1.4%
Perf Month
26.64%
Perf Quarter
37.77%
Perf Half Y
33.03%
-
-
-
-
Beta
1.096
-
-
Volatility
0.07%, 0.2%
Prev Close
0.69%
Price
2.9
Change
0.52%
RHE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 11.93 | 10.41 | 15.39 | 20.23 | 9.14 | |
| Net income per share | 0.14 | -1.98 | -1.53 | -8.5 | -2.07 | |
| Operating cash flow per share | 1.42 | 0.77 | 2.82 | -2.02 | 1.98 | |
| Free cash flow per share | 1.39 | 0.5 | 2.75 | -2.18 | 1.47 | |
| Cash per share | 2.6 | 2.48 | 3.92 | 0.47 | 2.23 | |
| Book value per share | 6.96 | 6.58 | 6 | 2.09 | 0.1 | |
| Tangible book value per share | 4.28 | 4.08 | 3.58 | -0.25 | -2.11 | |
| Share holders equity per share | 6.96 | 6.58 | 6 | 2.09 | 0.1 | |
| Interest debt per share | 63.81 | 60.21 | 50.52 | 33.96 | 28.84 | |
| Market cap | 2.36M | 6.04M | 7.82M | 5.9M | 3.81M | |
| Enterprise value | 92.61M | 92.18M | 85.96M | 60.46M | 53.28M | |
| P/E ratio | 9.81 | -1.81 | -2.94 | -0.39 | -0.98 | |
| Price to sales ratio | 0.12 | 0.34 | 0.29 | 0.16 | 0.22 | |
| POCF ratio | 0.99 | 4.67 | 1.6 | -1.64 | 1.03 | |
| PFCF ratio | 1.01 | 7.15 | 1.64 | -1.52 | 1.38 | |
| P/B Ratio | 0.2 | 0.54 | 0.75 | 1.59 | 20.6 | |
| PTB ratio | 0.2 | 0.54 | 0.75 | 1.59 | 20.6 | |
| EV to sales | 4.6 | 5.24 | 3.22 | 1.68 | 3.1 | |
| Enterprise value over EBITDA | 10.41 | 18.19 | 21.62 | 9.62 | 36.72 | |
| EV to operating cash flow | 38.65 | 71.18 | 17.57 | -16.81 | 14.35 | |
| EV to free cash flow | 39.61 | 109.09 | 18.02 | -15.59 | 19.35 | |
| Earnings yield | 0.1 | -0.55 | -0.34 | -2.56 | -1.02 | |
| Free cash flow yield | 0.99 | 0.14 | 0.61 | -0.66 | 0.72 | |
| Debt to equity | 8.72 | 8.9 | 8.17 | 15.55 | 277.75 | |
| Debt to assets | 0.9 | 0.92 | 0.8 | 0.84 | 0.83 | |
| Net debt to EBITDA | 10.15 | 17 | 19.65 | 8.68 | 34.09 | |
| Current ratio | 3.07 | 3.29 | 2.4 | 1.84 | 1.53 | |
| Interest coverage | 1.04 | 0.83 | 0.52 | 1.54 | -0.29 | |
| Income quality | 0.44 | -1.88 | -4.14 | 0.52 | -0.95 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.16 | 0.19 | 0.15 | 0.13 | 0.23 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.04 | 0.04 | 0.04 | 0.06 | 0.07 | |
| Capex to operating cash flow | -0.02 | -0.35 | -0.03 | 0.08 | -0.26 | |
| Capex to revenue | 0 | -0.03 | 0 | -0.01 | -0.06 | |
| Capex to depreciation | -0.02 | -0.16 | -0.05 | -0.12 | -0.42 | |
| Stock based compensation to revenue | 0 | 0 | 0.02 | 0.01 | 0.02 | |
| Graham number | 4.73 | 17.12 | 14.38 | 20 | 2.14 | |
| ROIC | 0 | 0.09 | 0.03 | 0.13 | -0.01 | |
| Return on tangible assets | 0 | -0.03 | -0.03 | -0.23 | -0.07 | |
| Graham Net | -48.63 | -44.77 | -46.39 | -26.83 | -28.66 | |
| Working capital | 11.66M | 11.98M | 12.27M | 6.5M | 3.3M | |
| Tangible asset value | 7.23M | 6.89M | 6.21M | -450K | -3.96M | |
| Net current asset value | -84.73M | -79.71M | -74.29M | -50.66M | -52.46M | |
| Invested capital | 8.72 | 8.9 | 8.17 | 15.55 | 277.75 | |
| Average receivables | 8.18M | 8.84M | 9.98M | 10.53M | 7.82M | |
| Average payables | 4.03M | 3.35M | 3.38M | 3.52M | 2.89M | |
| Average inventory | 9.15M | 19.44M | 10.26M | 8.64M | 8.64M | |
| Days sales outstanding | 153.68 | 191.11 | 147.2 | 104.65 | 113.73 | |
| Days payables outstanding | 184.8 | 151.79 | 83.55 | 46.32 | 70.1 | |
| Days of inventory on hand | 917.65 | 1.04K | 0 | 243 | 0 | |
| Receivables turnover | 2.38 | 1.91 | 2.48 | 3.49 | 3.21 | |
| Payables turnover | 1.98 | 2.4 | 4.37 | 7.88 | 5.21 | |
| Inventory turnover | 0.4 | 0.35 | 16.38M | 1.5 | 0 | |
| ROE | 0.02 | -0.3 | -0.26 | -4.06 | -21.02 | |
| Capex per share | -0.03 | -0.27 | -0.07 | -0.16 | -0.51 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 5.73 | 2.1 | 2.44 | 2.2 | 2.46 | |
| Net income per share | -3.8 | -1.07 | -0.36 | -0.52 | -0.13 | |
| Operating cash flow per share | -0.8 | 1.39 | 0.19 | 0.27 | 0.14 | |
| Free cash flow per share | -0.86 | 1.39 | -0.26 | 0.24 | 0.11 | |
| Cash per share | 0.48 | 1.51 | 1.02 | 0.76 | 2.28 | |
| Book value per share | 2.1 | 0.97 | 0.68 | 0.21 | 0.1 | |
| Tangible book value per share | -0.25 | -1.26 | -1.53 | -2 | -2.15 | |
| Share holders equity per share | 2.1 | 0.97 | 0.68 | 0.21 | 0.1 | |
| Interest debt per share | 33 | 30.75 | 30.44 | 29.66 | 28.31 | |
| Market cap | 5.88M | 6.35M | 6.78M | 4.07M | 3.73M | |
| Enterprise value | 60.44M | 58.2M | 59.93M | 56.97M | 53.2M | |
| P/E ratio | -0.22 | -0.8 | -2.47 | -1.05 | -3.92 | |
| Price to sales ratio | 0.58 | 1.63 | 1.47 | 0.98 | 0.83 | |
| POCF ratio | -4.13 | 2.44 | 18.94 | 8.05 | 14.81 | |
| PFCF ratio | -3.86 | 2.45 | -13.72 | 9.18 | 17.78 | |
| P/B Ratio | 1.58 | 3.52 | 5.32 | 10.51 | 20.18 | |
| PTB ratio | 1.58 | 3.52 | 5.32 | 10.51 | 20.18 | |
| EV to sales | 5.95 | 14.9 | 13.03 | 13.77 | 11.76 | |
| Enterprise value over EBITDA | 17.3 | -74.04 | 86.1 | 218.26 | 78.58 | |
| EV to operating cash flow | -42.41 | 22.41 | 167.4 | 112.8 | 211.12 | |
| EV to free cash flow | -39.69 | 22.43 | -121.31 | 128.59 | 253.34 | |
| Earnings yield | -1.14 | -0.31 | -0.1 | -0.24 | -0.06 | |
| Free cash flow yield | -0.26 | 0.41 | -0.07 | 0.11 | 0.06 | |
| Debt to equity | 15.55 | 31.35 | 44.43 | 142.48 | 277.75 | |
| Debt to assets | 0.84 | 0.86 | 0.86 | 0.86 | 0.83 | |
| Net debt to EBITDA | 15.62 | -65.96 | 76.36 | 202.68 | 73.07 | |
| Current ratio | 1.84 | 1.57 | 1.55 | 1.47 | 1.53 | |
| Interest coverage | 4.32 | -1.07 | 0.27 | -0.57 | 0.23 | |
| Income quality | 0.64 | -1.3 | -0.52 | -0.52 | -1.06 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.12 | 0.31 | 0.22 | 0.23 | 0.17 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.07 | |
| Capex to operating cash flow | 0.07 | 0 | -2.38 | -0.12 | -0.17 | |
| Capex to revenue | -0.01 | 0 | -0.19 | -0.01 | -0.01 | |
| Capex to depreciation | -0.17 | 0 | -1.21 | -0.12 | -0.08 | |
| Stock based compensation to revenue | 0.01 | 0.02 | 0.03 | 0.02 | 0.01 | |
| Graham number | 13.39 | 4.83 | 2.35 | 1.55 | 0.54 | |
| ROIC | 0.13 | -0.01 | 0.01 | -0.01 | 0 | |
| Return on tangible assets | -0.1 | -0.03 | -0.01 | -0.02 | 0 | |
| Graham Net | -26.91 | -30.28 | -26.78 | -27.01 | -29.26 | |
| Working capital | 6.5M | 4.51M | 4.07M | 3.37M | 3.3M | |
| Tangible asset value | -450K | -2.36M | -2.88M | -3.76M | -3.96M | |
| Net current asset value | -50.66M | -51.72M | -53.06M | -53.06M | -52.46M | |
| Invested capital | 15.55 | 31.35 | 44.43 | 142.48 | 277.75 | |
| Average receivables | 11.51M | 8.45M | 6.63M | 6.29M | 5.64M | |
| Average payables | 3.39M | 3.23M | 3.1M | 2.91M | 2.64M | |
| Average inventory | 8.64M | 8.64M | 7.23M | 14.12M | 6.89M | |
| Days sales outstanding | 91.29 | 152.21 | 130.26 | 128.87 | 106.44 | |
| Days payables outstanding | 44.08 | 100.57 | 111.34 | 95.67 | 74.59 | |
| Days of inventory on hand | 231.22 | 0 | 530.28 | 473.45 | 0 | |
| Receivables turnover | 0.99 | 0.59 | 0.69 | 0.7 | 0.85 | |
| Payables turnover | 2.04 | 0.89 | 0.81 | 0.94 | 1.21 | |
| Inventory turnover | 0.39 | 2.83M | 0.17 | 0.19 | 0 | |
| ROE | -1.81 | -1.11 | -0.54 | -2.51 | -1.29 | |
| Capex per share | -0.06 | 0 | -0.45 | -0.03 | -0.02 |
RHE Frequently Asked Questions
What is Regional Health Properties, Inc. stock symbol ?
Regional Health Properties, Inc. is a US stock , located in Suwanee of Ga and trading under the symbol RHE
What is Regional Health Properties, Inc. stock quote today ?
Regional Health Properties, Inc. stock price is $2.9 today.
Is Regional Health Properties, Inc. stock public?
Yes, Regional Health Properties, Inc. is a publicly traded company.
Company Profile
- Volume Average 5.15K
- Market Capitalization 5.15M
- Employee 114
- CEO Mr. Brent S. Morrison CFA
- Headquarters Suwanee,GA,US
- IPO Date 2017-10-09
-
Website
https://regionalhealthproperties.com 
Regional Health Properties, Inc., through its subsidiaries, operates as a self-managed real estate investment company that invests primarily in real estate purposed for long-term care and senior living. Its business principally consists of leasing and subleasing such facilities to third-party tenants, which operate the facilities. The company's facilities provide a range of healthcare services to patients and residents, including skilled nursing and assisted living services, social services, various therapy services, and other rehabilitative and healthcare services for long-term and short-stay patients and residents. As of December 31, 2021, it owned, leased, or managed 24 facilities primarily in the Southeastern United States of America. The company was incorporated in 1991 and is headquartered in Suwanee, Georgia.
